Nike (NKE) is facing significant headwinds in its turnaround efforts, with its stock down approximately 60% over the past five years. Following the rehiring of veteran Elliott Hill in late 2024 to lead the company’s recovery, investors are growing impatient as competition intensifies from brands like Lululemon and athlete-driven labels. The upcoming earnings report on March 31 is critical, as analysts predict a year-over-year decline in earnings per share (EPS) to $0.29 on flat revenue of $11.22 billion, raising concerns about the effectiveness of Hill’s strategy.
The financial implications are notable, as Nike grapples with rising costs from tariffs—estimated to add $1.5 billion in expenses this fiscal year—and challenges in key markets like China. While BTIG analyst Robert Drbul maintains a buy rating with a revised price target of $90, the stock trades around $53, reflecting cautious investor sentiment amid a challenging landscape.
For market professionals, the key takeaway is to monitor Nike’s March 31 earnings closely. While the stock may appear undervalued, the path to recovery is likely to be lengthy, making it crucial to assess management’s guidance and operational adjustments before making investment decisions.
Source: fool.com